These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22047200)

  • 1. Type of steatosis influences microcirculation and fibrogenesis in different rat strains.
    Rosenstengel S; Stoeppeler S; Bahde R; Spiegel HU; Palmes D
    J Invest Surg; 2011; 24(6):273-82. PubMed ID: 22047200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and strain-specific differences in the development of steatosis in rats.
    Stöppeler S; Palmes D; Fehr M; Hölzen JP; Zibert A; Siaj R; Schmidt HH; Spiegel HU; Bahde R
    Lab Anim; 2013 Jan; 47(1):43-52. PubMed ID: 23467489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.
    Liebig M; Hassanzada A; Kämmerling M; Genz B; Vollmar B; Abshagen K
    Exp Biol Med (Maywood); 2018 Jan; 243(1):1-12. PubMed ID: 29065724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rats on a high-energy diet showing no weight gain present with ultrastructural changes associated with liver fibrosis.
    Oberholzer HM; Bester MJ; van der Schoor C
    Ultrastruct Pathol; 2013 Aug; 37(4):267-72. PubMed ID: 23672266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats.
    Kučera O; Garnol T; Lotková H; Staňková P; Mazurová Y; Hroch M; Bolehovská R; Roušar T; Červinková Z
    Physiol Res; 2011; 60(2):317-28. PubMed ID: 21114362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.
    Kitamori K; Naito H; Tamada H; Kobayashi M; Miyazawa D; Yasui Y; Sonoda K; Tsuchikura S; Yasui N; Ikeda K; Moriya T; Yamori Y; Nakajima T
    Environ Health Prev Med; 2012 May; 17(3):173-82. PubMed ID: 21853259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet.
    Thompson MD; Cismowski MJ; Trask AJ; Lallier SW; Graf AE; Rogers LK; Lucchesi PA; Brigstock DR
    Gene Expr; 2016; 17(1):47-59. PubMed ID: 27342733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.
    Okada Y; Yamaguchi K; Nakajima T; Nishikawa T; Jo M; Mitsumoto Y; Kimura H; Nishimura T; Tochiki N; Yasui K; Mitsuyoshi H; Minami M; Kagawa K; Okanoue T; Itoh Y
    Liver Int; 2013 Feb; 33(2):301-11. PubMed ID: 23295058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids.
    El-Badry AM; Moritz W; Contaldo C; Tian Y; Graf R; Clavien PA
    Hepatology; 2007 Apr; 45(4):855-63. PubMed ID: 17393510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of macrovesicular and microvesicular hepatic steatosis in rats using 3.0-T ¹H-magnetic resonance spectroscopy.
    Ou HY; Chao PH; Yu PC; Wei YC; Chen CL; Yu CY; Chiu TM; Chang YC; Lai CY; Cheng YF
    Transplant Proc; 2012 May; 44(4):955-8. PubMed ID: 22564595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.
    Carter-Kent C; Brunt EM; Yerian LM; Alkhouri N; Angulo P; Kohli R; Ling SC; Xanthakos SA; Whitington PF; Charatcharoenwitthaya P; Yap J; Lopez R; McCullough AJ; Feldstein AE
    J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):190-7. PubMed ID: 21240012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids.
    D'souza AM; Beaudry JL; Szigiato AA; Trumble SJ; Snook LA; Bonen A; Giacca A; Riddell MC
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G850-63. PubMed ID: 22268100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.
    Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB
    Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
    Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
    Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.
    Pasarín M; La Mura V; Gracia-Sancho J; García-Calderó H; Rodríguez-Vilarrupla A; García-Pagán JC; Bosch J; Abraldes JG
    PLoS One; 2012; 7(4):e32785. PubMed ID: 22509248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis.
    Ijaz S; Yang W; Winslet MC; Seifalian AM
    Microvasc Res; 2005 Nov; 70(3):129-36. PubMed ID: 16203017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.
    Wang L; Wu S; Cai M; Ma J; Li S; Li M; Xu Y; Wei L; Shang J
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
    Huang Y; Fu JF; Shi HB; Liu LR
    Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease.
    Apte UM; McRee R; Ramaiah SK
    Toxicol Pathol; 2004; 32(5):567-76. PubMed ID: 15603541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.